新产品
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 204504 | Zegocractin ( CM-4620 ) | 1713240-67-5 | ≧98.0% | _1713240-67-5.png) |
| Zegocractin (CM-4620, Auxora(TM)) 是钙释放激活钙通道蛋白 1（CRAC 通道， | ||||
| S-203041 | 4-(2,2,2-三氟乙氧基)苯基硼酸 | 886536-37-4 | 95% | phenyl]boronic_acid_886536-37-4.png) |
| g scale to Kg scale may be provided. | ||||
| 262324 | 2-(3-Fluoro-4-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 1350426-06-0 | 98% Min. | -4,4,5,5-tetramethyl-1,3,2-dioxaborolane_1350426-06-0.png) |
| 52004 | Belnacasan | 273404-37-8 | 98% | _273404-37-8.png) |
| Belnacasan (VX-765) 是 VRT-043198 的口服生物活性前药，VRT-043198 是有效 | ||||
| 2073107 | Trilaciclib hydrochloride (G1T28 hydrochloride) | 1977495-97-8 | 98% Min. | .png) |
| Trilaciclib是一种小分子竞争性细胞周期蛋白依赖性激酶4和6（CDK4 / | ||||
| 2091906 | BAY-2416964 | 2242464-44-2 | 98% Min. |  |
| BAY-2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist | ||||
| 20103001 | ASN007 | 2055597-12-9 | ≧98.0% |  |
| ASN007 , a novel oral ERK inhibitor , has shown anti-tumor activity in both solid tum | ||||
| 20103002 | Senaparib | 1401682-78-7 | ≧98.0% |  |
| Senaparib (IMP4297) is a novel agent targeting PARP (poly-ADP ribose polymerase) with | ||||
| 201221 | Razuprotafib sodium | 1809275-69-1 | ≧98.0% |  |
| Razuprotafib，也称为AKB-9778，是血管内皮蛋白酪氨酸磷酸酶（VE-PTP） | ||||
| 20123101 | Samelisant | 1415792-84-5 | ≧98.0% |  |
| Samelisantis a novel, highly selective and potent small molecule oral inhibitor targe | ||||
| 26188 | Firibastat ( QGC-001 ) | 648927-86-0 | ≧98.0% | _648927-86-0.png) |
| Firibastat, (originally named QGC001) is the first drug candidate of a new class of c | ||||
| 21236 | Centanafadine HCl | 923981-14-0 | ≧98.0% |  |
| Centanafadine, also known as EB-1020, is an adrenergic uptake inhibitor and dopamine | ||||